Medical Devices
HeartBeam Study Shows Comparable Accuracy to Standard ECG in Arrhythmia Detection
HeartBeam's 3D ECG system demonstrates comparable accuracy to standard 12-lead ECGs in detecting arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.
Nutriband Showcases AVERSA™ Abuse-Deterrent Technology Addressing Opioid Crisis at Emerging Growth Conference
Nutriband Inc. presented its AVERSA™ abuse-deterrent transdermal technology at the August 2025 Emerging Growth Conference, projecting peak annual sales of $200 million for its fentanyl patch upon FDA approval with potential to exceed $800 million, offering a critical solution to the ongoing opioid epidemic.
HeartBeam Study Shows Comparable Accuracy Between Portable 3D ECG System and Standard 12-Lead ECG
HeartBeam Inc. reported study results demonstrating that its portable 3D ECG system achieves comparable accuracy to standard 12-lead ECGs in detecting cardiac arrhythmias, potentially expanding advanced cardiac monitoring to non-clinical settings.
Holistix Introduces Red Light Therapy Slippers for At-Home Foot Pain Relief
Holistix International's new SKO Red Light Therapy Slippers offer a convenient, science-backed alternative to traditional foot pain treatments, potentially transforming how millions manage chronic foot conditions at home.
Izotropic Corporation Secures Exclusive U.S. Patent for AI-Powered Breast Cancer Diagnosis Technology
Izotropic Corporation has obtained the exclusive U.S. patent for computer-aided diagnosis using breast CT technology, positioning the company to address critical limitations in current breast cancer screening methods through AI-powered image analysis.
Sigyn Therapeutics Expands Cardiovascular Disease Study to Target Lipoprotein Reduction
Sigyn Therapeutics plans a clinical feasibility study of its blood purification technology that could address cardiovascular disease in high-risk patients while potentially extending lives of end-stage renal disease patients and generating significant economic impact.
HeartBeam's Portable ECG Device Enables Hospital-Level Cardiac Monitoring Outside Clinical Settings
HeartBeam's credit-card-sized FDA-cleared device synthesizes 12-lead ECGs from 3D signals, potentially transforming remote cardiac care by providing on-demand arrhythmia evaluation and integration with automated interpretation software.
HeartBeam to Showcase FDA-Cleared Cardiac Technology at Major Investor Conferences
HeartBeam Inc. executives will present the company's innovative cable-free 3D ECG technology at three September investor conferences, highlighting progress in commercializing a device that could transform remote cardiac care.
HeartBeam's Cable-Free ECG Technology Advances At-Home Cardiac Monitoring
HeartBeam's FDA-cleared portable ECG system enables patients to capture high-fidelity heart measurements at home, potentially improving early detection of arrhythmias and transforming cardiac care through convenient remote monitoring.
HeartBeam Receives FDA Clearance for Revolutionary Cable-Free ECG System
HeartBeam Inc. has obtained FDA clearance for its groundbreaking cable-free 12-lead ECG system that enables remote cardiac monitoring, potentially transforming how patients and physicians access critical arrhythmia data outside traditional clinical settings.
Izotropic Corporation Announces $300K Private Placement and Warrant Extension for Breast Cancer Imaging Technology
Izotropic Corporation's $300,000 private placement and warrant extension provides crucial working capital to advance its breast cancer imaging technology development.
HeartBeam Secures New Patents to Advance 3D ECG Technology for Remote Cardiac Monitoring
HeartBeam Inc. has strengthened its intellectual property portfolio with two new U.S. patents that enhance its innovative 3D ECG platform, positioning the company to transform remote cardiac care by enabling patients and physicians to monitor and diagnose heart conditions outside medical facilities.
Lionheart Health Named Finalist in Octane's 2025 Medical Technology Innovation Awards
Lionheart Health's recognition as a finalist in Octane's High Tech Awards highlights its breakthrough whole body regeneration chamber technology that could extend human healthspan by 20 years through AI-driven organ regeneration.
Izotropic Corporation Launches BreastCT.com to Promote Advanced Breast Cancer Detection Technology
Izotropic Corporation has launched BreastCT.com as an educational platform to raise awareness about its dedicated breast CT technology, which aims to improve cancer detection in women with dense breast tissue, potentially transforming breast cancer screening and diagnosis.
Branded Legacy, Inc. Expands into Biotech and Medical Devices with Acquisition of Bio Legacy Evaluative Group
Branded Legacy, Inc. (OTC: BLEG) has acquired Bio Legacy Evaluative Group, marking its entry into the biotech and medical devices sector with a focus on addressing global health challenges.
Lionheart Health Recognized as Top Implantable Stimulator Developer by MedTech Outlook
Lionheart Health, Inc. has been awarded the Top Implantable Stimulator Developer of the Year by MedTech Outlook for its innovative KlothoImplant™ and MicroImplant™ technologies, marking a significant advancement in medical device technology aimed at healthspan and organ regeneration.
HeartBeam Inc. Advances Toward FDA Clearance with Promising Q2 2025 Results
HeartBeam Inc. reports significant progress toward FDA clearance for its innovative 12-lead ECG synthesis software, highlighting its potential to revolutionize cardiac care outside medical facilities.
Hydromer, Inc. Announces Preliminary Financial Results for Q2 2025
Hydromer, Inc. reports a 14% revenue increase in Q2 2025 despite a net loss, highlighting strategic investments for future growth in the medical device sector.
Vycor Medical Reports Significant Growth in Revenue and Operating Profit for First Half of 2025
Vycor Medical, Inc. announces a notable increase in revenue and operating profit for the first six months of 2025, driven by international expansion and advancements in its neurosurgical and vision rehabilitation technologies.
OxyEdge™ 2.0 ATA Sitting Hard Shell Hyperbaric Chamber Introduces a New Standard in Hyperbaric Oxygen Therapy
The OxyEdge™ 2.0 ATA Sitting Hard Shell Hyperbaric Chamber revolutionizes hyperbaric oxygen therapy with its advanced technology, comfort, and affordability, making it accessible for both home and clinical use.
SOBRsafe Inc. Secures European Patent for Innovative Alcohol Detection Technology
SOBRsafe Inc. has been granted a European patent for its SOBRcheck device, marking a significant advancement in noninvasive alcohol monitoring technology with implications for workplace safety and judicial compliance.
HeartBeam Inc.'s FDA-Cleared System Revolutionizes Cardiac Care with Portable Technology
HeartBeam Inc.'s innovative, FDA-cleared portable ECG system marks a significant advancement in cardiac care by enabling arrhythmia monitoring outside traditional clinical settings.
HeartBeam Inc. Strengthens Cardiac Diagnostics with Two New U.S. Patents
HeartBeam Inc. has secured two new U.S. patents, enhancing its cardiac monitoring technology and intellectual property portfolio, marking a significant step forward in portable and accurate heart health diagnostics.
TG Orthodontics Introduces Lightforce Braces for Customized Smile Transformations
TG Orthodontics in Marlboro Township now offers Lightforce braces, a customizable and efficient orthodontic solution that enhances smiles and boosts confidence for patients of all ages.
Former ENT&A CEO Bob Glazer Joins Prosidio as Strategic Advisor to Enhance Endoscopy Accessibility
Bob Glazer, former CEO of ENT and Allergy Associates, joins Prosidio as a strategic advisor to help expand access to affordable, high-quality endoscopy technology for outpatient practices.
United Health Products Awaits FDA Response on Regulatory Hurdles
United Health Products, Inc. faces regulatory challenges with the FDA over its Investigational Device Exemption application and a 2015 Warning Letter, impacting its path to market for its hemostatic gauze product.
HeartBeam Inc. to Discuss Q2 Results and Business Updates in August Conference Call
HeartBeam Inc. (NASDAQ: BEAT) is set to discuss its second-quarter results and provide updates on regulatory initiatives and commercial-readiness activities during a conference call on August 13, 2025, highlighting its progress in transforming cardiac care with innovative technology.
Izotropic Corp. Advances Breast Cancer Imaging with Exclusive Breast CT Technology
Izotropic Corp. is pioneering a patient-centric alternative to mammography for dense breast tissue imaging, with exclusive global rights to Breast CT technology and upcoming U.S. clinical trials.
NanoCell Therapeutics' NCtx Platform Could Revolutionize CAR-T Therapy Accessibility
NanoCell Therapeutics' research demonstrates a novel method for in vivo CAR-T cell generation, potentially reducing costs and increasing access to life-saving cancer treatments.
Xtant Medical Collaborates with B2i Digital to Highlight Orthobiologics Innovation to Investors
Xtant Medical's partnership with B2i Digital aims to educate investors on its orthobiologics platform and market potential, showcasing its growth in the medical technology sector.